Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor, suzetrigine, for treating painful lumbosacral radiculopathy. Shares down.
Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbar ...
A new study has found a potential breakthrough in the treatment of chronic pain and doesn't rely on addictive opiate ...
Up until now, one of the most common ways to treat chronic pain has been ... discovered a new way to tackle chronic pain - ...
Chronic pain can have huge impacts on patients and their families. We discuss its prevalence and emerging therapies with Asal ...
Peripheral neuropathy is a condition that affects the nerves outside the brain and spinal cord. It can cause pain, tingling, ...
A major breakthrough in our understanding of pain has been revealed in a collaborative study led by a Leeds scientist, ...
If you’re suffering from stabbing pain, numbness, tingling, or a burning sensation in your arms, legs, hands, or feet, you may be experiencing peripheral neuropathy. If you or a loved ...
A team of researchers from Weill Cornell Medicine and the Burke Neurological Institute has developed a groundbreaking drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback